In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor make melanoma, a deadly skin cancer, more likely to spread in patients age 70 and older. Their research, published in the peer-reviewed journal Cancer Research, could lead to new therapies to help prevent melanoma metastasis.
Health Professionals
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Protein linked to Parkinson’s also found to drive melanoma growth
A small protein involved in neurodegeneration leading to Parkinson’s disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.